Pharmacopsychiatry

Article	Citations
An Oppositional Tolerance Account for Potential Cognitive Deficits Caused by the Discontinuation of Antidepressant Drugs	157
2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation	60
Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study	46
SARS-CoV-2-Infection in People Addicted to Illegal Drugs – Is There a Protective Effect of Opioid Maintenance Treatment?	23
	22
Challenges Related to the Implementation of Measurement-Based Care for the Treatment of Major Depressive Disorder: A Feasibility Study	19
Neuronal Correlates of Delusional Symptomatology in Affective and Psychotic Disorders	18
Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries	17
The Role of Circadian Rhythmicity and CLOCK Genes in Psychiatry	17
The Role of Mood Stabilizers in Children and Adolescents with Anorexia Nervosa: A 1-year Follow-Up, Propensity Score-Matched Study	16
CircRNAs in Peripheral Blood: Potential Biomarkers for Alzheimer’s Disease?	15
Predicting mental health symptoms with NBS-Predict	15
The Mini-TRH Test	14
Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports	13
	13
Amphiphysin und GAD65 IgG Antikörper bei Zwangsstörungen	12
	12
Effects of Pharmacokinetic Gene Variation on Therapeutic Drug Levels and Antidepressant Treatment Response	11
Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USA	10
GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS	9
Epigenetics for Drug Discovery: Dissecting the Effect of High Antipsychotic Dosage and D2 Blockage on Peripheral DNA Methylation	9
News on the Role of Antidepressants in and for COVID-19 and Long COVID	8
	8
Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey	7
Patient and Physician Exposure to Artificial Intelligence Hype	7

	6
	6
Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes	6
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie	6
Impaired nonverbal communication is associated with symptom severity in Depression	5
Comparison of Sodium Lactate Infusion and Carbon Dioxide Inhalation Panic Provocation Tests: A Meta-analysis	5
Effects of Anesthesia Changes During Maintenance ECT: A Longitudinal Comparison of Seizure Quality Under Anesthesia Using Propofol/Esketamine Versus Methohexita	5
	5
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannab	5
Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review	4
Increased Odds of Cognitive Impairment in Adults with Depressive Symptoms and Antidepressant Use	4
	4
The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics	4
Linkage of Young Mania Rating Scale to Clinical Global Impression Scale to Enhance Utility in Clinical Practice and Research Trials	4
Longitudinal Multimodal Analysis of Structural Brain Changes and Psychopathology Using Data-Driven Fusion Approaches	4
Overview: Chronic Pain and Cannabis-Based Medicines	4
Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis	4
Does Lidocaine Shorten Seizure Duration in Electroconvulsive Therapy?	4
Revisiting the World’s Strictest COVID-19 Lockdown: Formidable Mental Health Challenges	3
Metformin is Protective Against the Development of Mood Disorders	3
Predicting one-year postoperative cognitive dysfunction after cardiac surgery by combining markers of amyloid-β and tau pathology	3
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs	3
Monitoring Anesthetic Depth Using the Patient State Index in Electroconvulsive Therapy Improves Seizure Quality	3
	3
Brain Fog reconsidered. Objectifying subjective cognitive impairment following COVID-19 infection.	3
Das therapeutische Potential von niedrig dosiertem Δ9-Tetrahydrocannabinol bei der Modulation der Alzheimer-Pathologie im 5xFAD-Mausmodell	3
Impact of Antipsychotic Medications on Weight Gain and Eating Disorder-Related Psychopathology in Adult Inpatients with Anorexia Nervosa	3
Investigating the role of CCL11 in shaping microglial age-and long-COVID-related inflammatory activation	3
Reward System in Schizophrenia: Characterizing Clinical and Neurobiological Underpinnings with Regard to Sexuality	3
In major depression early response to antidepressant treatment in week one is associated with FKBP5-gene variants rs1360780 and rs4713916	2
Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study	2
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatme	2
Development of a Genetic Test Indicating Increased AVP/V1b Signalling in Patients with Acute Depression	2
	2
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie	2
Digital Phenotyping and Mobile Sensing in Addiction Psychiatry	2
Early phase of a seronegative autoimmune psychosis with increased kappa free light chains	1
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine	1
Medical Cannabis Legalization: No Contribution to Rising Stimulant Rates in the USA	1
Systematic Review and Meta-Analysis of L-Methylfolate Augmentation in Depressive Disorders	1
Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis	1
Reward System in Schizophrenia: Characterizing Clinical and Neurobiological Underpinnings with Regard to Sexuality	1
Implications of Online Self-Diagnosis in Psychiatry	1
	1
Impact of Parkinson Medication on Neuropsychiatric and Neurocognitive Symptoms in Patients with Advanced Parkinson Disease Prior to Deep Brain Stimulation	1
Einfluss einer traumafokussierten Psychotherapie auf Zwangs- und somatoformen Symptome: Design einer klinischen Längsschnittstudie	1
CYP1A2 Genotyp-abhängige Auswirkung des Rauchens auf die Mirtazapin Serumkonzentration	1
Therapeutic Potential of the Novel GLP-1 Receptor Agonist Semaglutide in Alcohol Use Disorder	1
Early Treatment-Resistance in First Episode Psychosis	1
Activation of Hippocampal Neuronal NADPH Oxidase NOX2 Promotes Depressive-Like Behaviour and Cognition Deficits in Chronic Restraint Stress Mouse Model	1

Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring	1
Human Derived Dermal Fibroblasts as in Vitro Research Tool to Study Circadian Rhythmicity in Psychiatric Disorders	1
Der Zusammenhang zwischen belastenden Lebensereignissen, DMN-Konnektivität und MDD- Remission: Eine fMRT-gestützte Analyse	0
Correction: Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multicenter, R	0
Effects of long-term thiethylperazine treatment on Alzheimer's pathology in Tg4-42 mice: Therapeutic Potential vs. Adverse Effects	0
Strategies and Management for Psychiatric Drug Withdrawal: A Systematic Review of Case Reports and Series	0
	0
	0
Psychedelics: A New Treatment Paradigm in Psychiatry?	0
Was heißt hier Remission? Eine Sekundäranalyse der longitudinalen EMC-Studie	0
	0
Expression Biomarkers of Pharmacological Treatment Outcomes in Women with Unipolar and Bipolar Depression	0
Differential impact of manic versus depressive episode recurrence on longitudinal gray matter volume changes in bipolar disorder	0
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels	0
The Effect of Electroconvulsive Therapy on Specific Catatonia Symptoms and Predictors of Late Response	0
	0
Establishing Core Symptoms of Acute Serotonin Reuptake Inhibitor Withdrawal: Results from an International Survey of Online Peer-Support Communities	0
Morphological Representation of C1q in the Aging Central Nervous System	0
Discontinuation Rate of Lurasidone and Quetiapine Extended Release in Bipolar Depression	0
Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review	0
A Trajectory of Long-Term Antipsychotic Medication Dosage in Inpatients with Severe Behavioral and Psychological Symptoms of Dementia: A Retrospective Study	0
Precision Psychiatry Approach to Treat Depression and Anxiety Targeting the Stress Hormone System – V1b-antagonists as a Case in Point	0
Transdiagnostic types of formal thought disorder and their association with gray matter brain structure: a model-based cluster analytic approach	0
Stratifizierung des Risikos für die Anwendung von Zwangsmaßnahmen mit Hilfe von künstlicher Intelligenz und elektronischen Gesundheitsdaten	0
Pentoxifylline as a Novel Add-on Therapy for Major Depressive Disorder in Adult Patients: A Randomized, Double-Blind, Placebo-Controlled Trial	0
Challenges and Ethical Considerations to Successfully Implement Artificial Intelligence in Clinical Medicine and Neuroscience: a Narrative Review	0
Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study	0
	0
Candidate Psychotropics against SARS – CoV – 2: A Narrative Review	0
Neural links of paranoia in a transdiagnostic sample	0
Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia	0
	0
Drug Combinations for Mood Disorders and Physical Comorbidities That Need Attention: A Cross-Sectional National Database Survey	0
Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice	0
Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Stu	0
	0
The BIPCOVID Study: Investigating Shared Genetic Pathways Between COVID-19 Susceptibility and Psychiatric Symptoms in Bipolar Disorder	0
Cannabinoids for Behavioral Symptoms in Dementia: An Overview	0
Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany	0
Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum D	0
Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic Review of Pipeline Developments	0
Arzneimittelsicherheit in der Psychiatrie Hautexanthem mit Eosinophilie unter Lithium	0
Effekte eines sechswöchigen hochfrequenten standardisierten Sportprogramms (SIWAS) auf die Herzfrequenzvariabilität bei Patient*innen mit psychiatrischen Erkrankungen	0
„Peter Müller Preis für Forschung im Bereich Schizophrenie“ in Höhe von 5.000€	0
Classic Psychedelic Drugs: Update on Biological Mechanisms	0
Association Study Between DRD2, DRD3 Genetic Polymorphisms and Adverse Reactions in Chinese Patients on Amisulpride Treatment	0
Rapid Antidepressant and Antisuicidal Effects of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression With or Without Low-Grade Inflammati	0
Correction: Lithium Therapy in Old Age: Recommendations from a Delphi Survey	0
High Prescribing and State-Level Variation in Z-Drug Use Among Medicare Patients	0
Patient Perspectives on Pharmacotherapy of Alcohol Dependence	0
DNA Methylation of POMC and NR3C1-1F and Its Implication in Major Depressive Disorder and Electroconvulsive Therapy	0
	0
Longitudinal Digital Mood Charting in Bipolar Disorder: Experiences with ChronoRecord Over 20 Years	0
Impact of Psychiatric and Related Somatic Medications on the Duration and Severity of COVID-19: A Retrospective Explorative Multi-center Study from the German M	0
Antipsychotic Monotherapy for Major Depressive Disorder: A Systematic Review and Meta-Analysis	0
Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?	0
ABC Family Gene Polymorphisms and Cognitive Functions Interact to Influence Antidepressant Efficacy	0
Association of Four Medication Classes and Non-suicidal Self-injury in Adolescents with Affective Disorders – A Retrospective Chart Review	0
Risk Phenotypes, Comorbidities, Pharmacotherapy, and Electroconvulsive Therapy (ECT) in a Cohort with Difficult-to-Treat Depression in Comparison to an Unmedica	0
Risperidone-Induced Leukoneutropenia: Evidence from a Positive Rechallenge and Review of the Literature	0
	0
Management of Refractory Functional Gastrointestinal Disorders: What Role Should Psychiatrists Have?	0
Initial Evidence of CES1 Gene Variants Influencing the Pharmacokinetics and Clinical Effects of Methylphenidate	0
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort Study	0
Selective Serotonin Reuptake Inhibitors may Influence COVID-19 Prognosis through Antioxidant and Cytoprotective Pathways Mediated by Sigma 1 Receptor Agonism	0
Rationale, Mission and Vision for a National Centre of Affective Disorders in Germany	0
Geschlechter im Fokus: Welche Rolle spielt der 5-HT2C-Rezeptor in der lateralen Habenula in einem Mausmodell der schweren Depression?	0
Cognitive Side Effects of Electroconvulsive Therapy: A Case-Control Comparison in Obsessive-Compulsive and Depressive Disorders	0
The Therapeutic Potential of Pimavanserin in the Treatment of Hallucinogen Induced Psychosis and Persistent Perceptual Symptoms	0
COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine	0
	0
Pharmacological Treatment of Autism Spectrum Disorder: A Systematic Review of Treatment Guidelines	0
Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry	0
Untersuchung des Sozialverhaltens in einem Rattenmodell der bipolaren Störung	0
Anti-SARS-CoV-2 Action of Fluvoxamine may be Mediated by Endothelial Nitric Oxide Synthase	0
A genome-wide association study of brain function across multiple cognitive domains	0
Neuroimaging-gestützte Charakterisierung von Schlafstörungen und Depressionen	0
„AGNP-Preis für Forschung in der Psychopharmakologie“ in Höhe von 5.000 €	0
	0
Dexmedetomidine in Psychiatry: Repurposing of its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating Properties	0

Citalopram als potenzielle Therapie und Prophylaxe für Alzheimer: Experimentelle Untersuchungen im 5xFAD-Mausmodell	0
Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multic	0
Medical Cannabis in Psychiatry	0
Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases	0
	0
Therapeutic Drug Monitoring of Cariprazine – Updated Values for a Dose-Related Reference Range	0
Cariprazine Orodispersible Tablet: A New Formulation for Cariprazine	0
Predicting Future Cognitive Decline Using Novel fMRI-Based Biomarkers in Preclinical Alzheimer's Disease	0
Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study	0
COVID-19 Prognosis in Association with Antidepressant Use	0
Lithium Therapy in Old Age: Recommendations from a Delphi Survey	0
	0
Evaluation of E-Cigarette Use in Opioid-Dependent Patients in Maintenance Treatment	0
Opportunities for Drug Repurposing of Serotonin Reuptake Inhibitors: Potential Uses in Inflammation, Infection, Cancer, Neuroprotection, and Alzheimer’s Disease	0
Interpersonal Needs, Mental Pain, and Hopelessness in Psychiatric Inpatients with Suicidal Ideation	0
Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial	0
Therapeutic Reference Range for Clozapine Plasma Levels in Parkinson’s Disease or Dementia: A Systematic Review and Individual Participant Data Meta-analysis	0
Covid-19: Contributions from Psychopharmacology	0
Comparable Psychotropic Prescription Rates After Hospital Discharge Between Patients with COVID-19 and Those With Non-COVID-19-Related Respiratory Infection	0
Entgiftung bei Alkoholabhängigen mit Clomethiazol oder Diazepam – Vergleich von Behandlungsvariablen	0
Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature	0
Diversion and Abuse of Prescribed Methylphenidate – A Survey of an Outpatient Clinic for Adult Persons with ADHD	0
Augmentation of Electroconvulsive Therapy with Oral Caffeine: A Retrospective Analysis of 40 Patients with Major Depression	0
A Possible Type IV Hypersensitivity Reaction to Older Antiepileptic Drugs During and After Recovery from COVID-19 Infection	0
Clozapine-Induced Stuttering: Case Report and Literature Review	0
How to Improve Methodological Issues in Clinical Trials to Confirm that Pentoxifylline is Useful as an Add-on Therapy for Major Depressive Disorder	0
Aripiprazole Once-Monthly Versus Oral Aripiprazole for Schizophrenia in the Maintenance Phase: A Systematic Review and Network Meta-Analysis	0
Valproic Acid Induced Thrombocytopenia in an Elderly Man with Schizoaffective Disorder: A Case Report	0
Baseline Working Memory Predicted Response to Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression	0
Hirnvolumetrie bei Patienten mit Alkoholabhängigkeit	0
Life-time Actionable Pharmacogenetic Drug Use: A Population-based Cohort Study in 86 040 Young People With and Without Mental Disorders in Denmark	0
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integratio	0
Effectiveness of Medical Cannabis for the Treatment of Depression: A Naturalistic Outpatient Study	0